Glembatumumab vedotin represents a novel method in malignancy therapy. This ADC carefully recognizes a molecule expressed on various tumor cells, releasing a powerful chemotherapeutic compound. Initial medical https://www.targetmol.com/compound/glembatumumab_vedotin